Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Retatrutide is an investigational drug under active development by Eli Lilly through the TRIUMPH Phase 3 clinical trial programs
4 weeks 28 syringes 1 syringe per injection
The changes are mostly internal
Gene modulation (in-vitro): GHK-Cu has been reported to shift the expression of many genes toward tissue repair in cultured cells [5]
research shows no additional benefit above 1 mg daily Important: Doses above 1 mg (1,000 mcg) daily showed no additional metabolic benefits in clinical research
Carrying syringes and vials raises practical and sometimes legal complications that a simple nasal spray bottle avoids
US$ 22.62
US$ 21.22
US$ 24.16
US$ 21.84
US$ 25.65
US$ 25.59
US$ 26.78
